Marisol Gómez holds a Bachelor's degree in Mathematics (U. Salamanca) and a Ph.D. in Mathematics (Public University of Navarra, UPNA). She also completed a University Specialization Program in Machine Learning at UPNA. She is currently a Full Professor in the research field of Algebra.
Marisol Gómez is the PI of the Algebra and Applications Group at Navarrabiomed.
From January 2018 to June 2024, she was the PI and coordinator of the Bioengineering and Health Biotechnologies Area at the Navarra Health Research Institute (IdISNA).
Her current research lines focus on the development of machine learning methods for multimodal information extraction and optimization techniques for processing biosignals.
She is the co-author of more than 90 publications, and has participated in 20 publicly funded research projects. She has co-supervised 8 PhD theses (5 completed, 3 ongoing). She regularly serves as a reviewer for JCR-indexed journals. Her citation metrics are: h-index: 18 (WoS), 20 (Scopus), 22 (Google Scholar).
She is also affiliated with the Institute for Advanced Materials and Mathematics of UPNA, a multidisciplinary research institute bringing together scientists in Mathematics, Physics, Chemistry, and Materials Science.
From August 22, 2019, to June 30, 2024, she held the position of Deputy Director of Strategic Planning and Quality at the Higher Technical School of Industrial, Computer, and Telecommunication Engineering (ETSIIIT) of UPNA. She is also co-leader of Work.
Package 41 ("Interterritorial Innovation Interfaces") in the UNITA European University alliance.
She is co-founder of two UPNA spin-off companies: Movalsys S.L., focused on multimodal analysis of human movement for health and sports applications and Tairel Data S.L., which offers AI-based personalized solutions and advanced data processing services.
She actively participates in science outreach activities, especially through the Women in Science and Technology Chair at UPNA, supported by the Government of Navarra.
World's Top 2% Scientists (Stanford University)
Dr. David Escors Murugarren is a Spanish researcher born in Pamplona, Navarre, in 1974. He earned a degree in Biological Sciences from the University of Navarre and completed his doctoral thesis at the Autonomous University of Madrid in 2002. His thesis focused on the structure of the coronavirus of transmissible porcine gastroenteritis and the encapsidation of its genome. After completing his doctorate, he continued his postdoctoral training as a Marie Curie researcher at University College London (UCL), where he collaborated on research about lentiviral vectors and their use in cancer immunotherapy. In 2013, he returned to Spain and joined the Navarrabiomed Research Center, where he leads the immunomodulation group. Dr. Escors specializes in oncological immunotherapy and has published more than one hundred articles, reviews, and book chapters. His research focuses on the development of new immunotherapies for solid tumors, and he has been awarded the V SER Navarra Award (Innovation Category) for his work in research on the
SARS-CoV-22.
(me dice copilot que a ver si no es : SARS-CoV-2)
Jacinto López Sagaseta has led the Protein Crystallography and Structural Immunology Unit since its creation in 2019. The Unit specializes in the experimental determination of the molecular structure of proteins and their interactions with other biological components (proteins, peptides, lipids, DNA, etc.).
He has been a researcher at international centers such as the University of Chicago
(2009-2015), Novartis Vaccines (2015-2016) and GSK Vaccines (2016-2017), where he led the experimental resolution of numerous TCR-antigen-MHC complexes and antibody-antigen. In 2010 he obtained a postdoctoral fellowship from the Ministry of Science, Innovation and Universities (Ref. 1046777, National Program for Mobility of Human Resources of the National Plan for R&D&I 2008-2011), in 2015 he was awarded a Marie-Curie fellowship by the European Commission (Grant 659615), and in 2018 with the Ramón y Cajal Program, from the Ministry of Science and Innovation (RYC-2017-21683). Among his recognitions, he holds the I3 accreditation from the Ministry of Universities and the accreditation as a Contracted Professor by Aneca. He is an invited reviewer for scientific journals as well as for the State Research Agency (AEI). The results of his research have been published in specialized journals, with him as lead author in articles published by Nature Communications, Blood, PNAS or EMBO Journal, as well as in immunology textbooks (Immunobiology, 9th Edition, Encyclopedia of Immunobiology, 2016).
Dr. Natalia López-Andrés has dedicated her scientific career to biology, graduating from this degree at the University of Navarra. She specialized in cardiovascular sciences by pursuing a PhD at the Division of Cardiovascular Sciences of the University of Navarra, obtaining the PhD in 2006. She holds a postdoctoral position at the Division of Cardiovascular Sciences in the Centre for Applied Medical Research from 2006 to 2008. During these years I worked with a multidisciplinary research team specialized in the study of heart failure. This expertise enabled her to occupy a postdoctoral position at INSERM, in unit U961, from 2008 until January 2013.
This unit focuses its research on the mechanisms of action and the diagnostic and therapeutic aspects applied to the field of cardiovascular stiffness-fibrosis and hypercoagulability. In 2013, I obtained the competitive Miguel Servet contract that allowed me to build a new research group in Navarrabiomed, the Translational cardiovascular research group, at the interface between clinical and basic research. Over the past 12 years my laboratory has investigated the role of Aldosterone/mineralocorticoid receptor and its biotargets in heart valve diseases. The research Programme is part of the “Cardiovascular and Renal Diseases Area” of the Health Research Institute of Navarra (IdiSNA). As part of my research career, I have effectively developed contacts and collaborations in other countries and universities to enhance her knowledge and capabilities. I have participated as a principal investigator in the European FP7 project Fibrotargets, as a work package leader in the COST action ADMIRE and as principal investigator in national and regional projects.
Eduardo Albéniz holds a medical degree (Medicine and Surgery) from the University of Navarra (1998) and specialized in Digestive System (MIR) at Ramón y Cajal Hospital in Madrid (1999-2003). Professionally, he has worked at HU Angers-France (2003), Hospital San Rafael in Madrid (2003-2004), and Complejo Hospitalario Universitario de Albacete (2004-2009). Since 2009, he has worked as a Consultant Gastroenterologist in the Endoscopy Unit of the Digestive System Service at the University Hospital of Navarra (HUN). Furthermore, since 2018 he combines his clinical activity with research thanks to several fellowships for Intensification (50% research activity; 50% clinical activity). These fellowships enabled him to complete his PhD in Medicine at the Public University of Navarra in 2021.
Dr. Albéniz has coordinated since 2013 the national Endoscopic Resection group of the Spanish Society of Digestive Endoscopy (SEED), whose main work is to promote national and international collaborative research in this field.
Since 2023, he has been a Member of the Board of Directors and Chair of the society´s scientific Committee. In addition, he coordinates the research activity of the Digestive System Service, the Resection and treatment unit for digestive motor disorders, and the CSUR functional unit for achalasia of the HUN.
Throughout his career, he has been a tutor for residents and, currently, he is directing 3 doctoral theses. He has participated in 38 research projects, 22 of them as PI and 10 of them awarded with competitive funding (SEED, ESGE, SVNPD, MEDTECH Navarra and ISCIII). He has also collaborated in the development of the European ESGE (European Society of Gastrointestinal Endoscopy) guidelines on Endoscopic Mucosal Resection and on training in POEM (Per-Oral Endoscopy Miotomy). As a result of this work, Dr. Albéniz is the author of more than 90 scientific publications in journals with a high impact index.